PT1117410E - Utilizacao de derivados de acido bisfosfonico para a preparacao de um medicamento destinado ao tratamento de coxeaduras - Google Patents

Utilizacao de derivados de acido bisfosfonico para a preparacao de um medicamento destinado ao tratamento de coxeaduras

Info

Publication number
PT1117410E
PT1117410E PT99946282T PT99946282T PT1117410E PT 1117410 E PT1117410 E PT 1117410E PT 99946282 T PT99946282 T PT 99946282T PT 99946282 T PT99946282 T PT 99946282T PT 1117410 E PT1117410 E PT 1117410E
Authority
PT
Portugal
Prior art keywords
alkylamino
pyridyl
bisphosphonic acid
coxeaduras
preparation
Prior art date
Application number
PT99946282T
Other languages
English (en)
Inventor
Du Mesnil Philippe
Bardon Thierry
Thibaud Dominique
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of PT1117410E publication Critical patent/PT1117410E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT99946282T 1998-10-02 1999-10-01 Utilizacao de derivados de acido bisfosfonico para a preparacao de um medicamento destinado ao tratamento de coxeaduras PT1117410E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812388A FR2784031B1 (fr) 1998-10-02 1998-10-02 Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries

Publications (1)

Publication Number Publication Date
PT1117410E true PT1117410E (pt) 2006-05-31

Family

ID=9531151

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99946282T PT1117410E (pt) 1998-10-02 1999-10-01 Utilizacao de derivados de acido bisfosfonico para a preparacao de um medicamento destinado ao tratamento de coxeaduras

Country Status (16)

Country Link
US (4) US6455514B2 (pt)
EP (1) EP1117410B1 (pt)
JP (1) JP2002526412A (pt)
AT (1) ATE314074T1 (pt)
AU (1) AU765284B2 (pt)
BR (1) BR9914257A (pt)
CA (1) CA2345364C (pt)
CY (1) CY1104974T1 (pt)
DE (1) DE69929218T2 (pt)
DK (1) DK1117410T3 (pt)
ES (1) ES2251226T3 (pt)
FR (1) FR2784031B1 (pt)
NZ (1) NZ510804A (pt)
PT (1) PT1117410E (pt)
WO (1) WO2000020008A1 (pt)
ZA (1) ZA200102510B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
WO2003095029A1 (en) * 2002-05-10 2003-11-20 F. Hoffmann-La Roche Ag Bisphosphonic acid for the treatment and prevention of osteoporosis
JP4463274B2 (ja) * 2003-06-27 2010-05-19 明 小谷 ビスホスホネート錯体
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
DE102005053512A1 (de) * 2005-11-09 2007-06-28 Omnimedic Gbr Verwendung von Clodronsäure zur Behandlung von Podotrochlose

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637641A (en) * 1970-01-16 1972-01-25 Diagnostic Data Inc Method of treating post-traumatic arthritis
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
DE3365492D1 (en) * 1982-01-27 1986-10-02 Schering Ag Diphosphonic acid derivatives and pharmaceutical preparations containing them
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
HU203198B (en) * 1987-10-26 1991-06-28 Sandoz Ag Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
DE69611569T2 (de) * 1995-05-19 2001-06-28 Canon Kk Toner für die Entwicklung elektrostatischer Bilder, sowie Verfahren zu ihrer Herstellung
PT854724E (pt) * 1995-09-29 2005-08-31 Novartis Ag Metodo de tratar a doenca navicular em cavalos
AU733075B2 (en) * 1996-09-26 2001-05-03 Oklahoma Medical Research Foundation Use of N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives in disease regression

Also Published As

Publication number Publication date
CA2345364C (fr) 2008-07-08
CA2345364A1 (fr) 2000-04-13
AU5870399A (en) 2000-04-26
FR2784031B1 (fr) 2002-02-01
DE69929218T2 (de) 2006-07-13
JP2002526412A (ja) 2002-08-20
US20010006960A1 (en) 2001-07-05
US20060183717A1 (en) 2006-08-17
US20040110726A1 (en) 2004-06-10
US20030032627A1 (en) 2003-02-13
WO2000020008A1 (fr) 2000-04-13
ES2251226T3 (es) 2006-04-16
US6696429B2 (en) 2004-02-24
EP1117410B1 (fr) 2005-12-28
BR9914257A (pt) 2001-07-03
DK1117410T3 (da) 2006-03-20
US6455514B2 (en) 2002-09-24
DE69929218D1 (de) 2006-02-02
FR2784031A1 (fr) 2000-04-07
US7915239B2 (en) 2011-03-29
EP1117410A1 (fr) 2001-07-25
CY1104974T1 (el) 2010-03-03
AU765284B2 (en) 2003-09-11
NZ510804A (en) 2003-12-19
ZA200102510B (en) 2001-09-28
ATE314074T1 (de) 2006-01-15

Similar Documents

Publication Publication Date Title
CA2120538A1 (en) Use of Bisphosphonic Acid Derivatives for Promoting Bone Repair and Corresponding Drugs
MY124122A (en) Heterocyclic derivatives
HUP0204114A2 (hu) Bifoszfonáttartalmú parenterális gyógyászati készítmény
KR890015738A (ko) 이포스폰산 유도체를 기제로 하는, 경구 투역용 약학적 조성물
SE8704248D0 (sv) Medical use
PL343706A1 (en) Heterocyclic derivatives which inhibit factor xa
NZ225408A (en) Acetohydroxamic acid derivatives and compositions thereof
GB9809349D0 (en) Heterocyclic derivatives
PT1117410E (pt) Utilizacao de derivados de acido bisfosfonico para a preparacao de um medicamento destinado ao tratamento de coxeaduras
HK1045464A1 (en) Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease
PL348108A1 (en) Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them
JPH10500977A (ja) ピリジルビスホスホン酸エステルよりなる治療用活性薬剤
ZA995321B (en) Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.
ES466795A1 (es) Un procedimiento para la produccion de imidazo(1,5-b)pirida-zinas
HUT34945A (en) Process for the production of new resorcionol-derivatives and of therapeutic prepartions containing them
HUT68396A (en) Method for preparing pharmaceutical preparation containing isoflavone derivative or salt of it
HK1024244A1 (en) 8h-thieno-(2,3-b)pyrrolizin-8-one compounds, a process for their preir preparation and pharmaceutical compositions containing them
IL87784A0 (en) Choline derivative,its preparation and pharmaceutical compositions containing it
JO1697B1 (en) Pyridine derivatives